
Agenus Stock: Immuno-Oncology Advancements Amidst Fiscal Pressures (NASDAQ:AGEN)
AmyKerk/iStock via Getty Images Introduction Agenus (NASDAQ:AGEN), a clinical-stage firm, specializes in therapies utilizing the body’s immune response to tackle cancer and infections. Through its subsidiaries, MiNK Therapeutics and SaponiQx, Agenus diversifies into adoptive cell […]